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Expression of mouse mammary tumor virus (MMTV)-encoded superantigens in B lymphocytes are required for viral
transmission and pathogenesis. Due to problems with detection and quantification of the superantigen protein, most reports
about the mechanism of superantigen expression from the viral sag gene rely on the quantitative analysis of putative sag
mRNAs. The description of multiple promoters as a source of putative sag mRNA has complicated the situation even further.
All conclusions about the level of superantigen protein expression based on these data remain circumstantial. To test the
effect of the glucocorticoid hormone dexamethasone on the total superantigen expression from an infectious MMTV provirus
we used a quantitative assay that is based on a superantigen–luciferase fusion protein. MMTV gene expression from the
major promoter in the 59 long terminal repeat (LTR) is strongly induced in the presence of glucocorticoid hormones. We now
demonstrate that, in the presence of dexamethasone, sag gene expression is reduced despite increased transcription from
the MMTV 59 LTR and increased amounts of putative sag mRNA initiated at the LTR promoter. These data show that the
expression of the MMTV sag gene does not correlate with the activity of the major LTR promoter and thus differs from all
other MMTV genes. © 2000 Academic Press
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Mouse mammary tumor virus (MMTV) is a murine
B-type retrovirus and causes a high incidence of mam-
mary gland carcinomas in infected females (Nandi and
McGrath, 1973). MMTV-induced T cell lymphomas are
observed at a lower incidence. Infectious MMTV is trans-
mitted from mother to offspring via milk (Bittner, 1936;
Hainaut et al., 1985) and, after passage through the
gastrointestinal tract, infection of B lymphocytes plays an
important role in the viral life cycle (Beutner et al., 1994;
Held et al., 1993a). MMTV encodes a superantigen (Sag)
which, when expressed on the surface of B cells or other
antigen-presenting cells, activates a large number of T
cells by interaction with specific T cell receptor b-chains
Acha Orbea and MacDonald, 1995; Pullen et al., 1990).
The resulting T cell response in turn stimulates the
infected B cells to proliferate (Held et al., 1993a) and thus
amplifies the number of virus-infected cells (Held et al.,
1993b) and potential target bystander cells. The subse-
quent clonal elimination of activated T cells results in a
progressive depletion of a specific T cell subset during
the course of the infection (Kappler et al., 1988). MMTV
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98can also be genetically inherited in the form of endoge-
nous proviruses (Mtv’s) in the host germ line. Sag ex-
pression from inherited proviruses usually leads to de-
pletion of T cell subsets expressing reactive T cell re-
ceptor b-chains (Frankel et al., 1991) but can also, as in
he SJL mouse model of follicular B cell lymphoma, in-
uce T-cell-dependent, interleukin-mediated proliferation
f B lymphoma cells (Tsiagbe et al., 1993).
The viral sag gene encoding the MMTV superantigen
s located within the 39 viral long terminal repeat (LTR).
ue to problems with detection and quantification of the
uperantigen protein, most reports about the mechanism
f superantigen expression rely on the quantitative anal-
sis of putative sag mRNAs. All conclusions about the
evel of superantigen protein based on these data remain
ircumstantial. The description of multiple promoters as
source of putative sag mRNA has complicated the
ituation even further. Subgenomic MMTV sag mRNAs,
initiated at four separate promoters and spliced to re-
move gag, pol, and env genes, have been described
under different conditions. Candidate promoters are the
classical promoter at the U3-R border [P1196, also called
1] (Cho et al., 1995; van Ooyen et al., 1983) used for the
xpression of all retroviral genomes and structural
enes, a second promoter within the U3 region [P698, also
designated P2] (Gu¨nzburg et al., 1993), a phorbol-ester-
nducible promoter in the env gene [P7246 or Penv] whichwas initially described as T-cell-specific but later also
found to be active in B lymphomas (Elliott et al., 1988;
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99MMTV Sag GENE EXPRESSIONMiller et al., 1992; Xu et al., 1997; Zhang et al., 1996), and
second, LTR-proximal promoter [P8498 or Penv2] (Arroyo et
l., 1997) within the env gene.
The effect of diverse stimuli on the total superantigen
xpression from an MMTV provirus can be directly
ested with a MHC class-II-independent superantigen
eporter assay on the basis of a recombinant superanti-
en–luciferase gene that we developed earlier (Reuss
nd Coffin, 1995, 1998). During pregnancy, basic MMTV
ene transcription is increased by glucocorticoid hor-
one interaction with steroid-hormone-responsive ele-
ents near the major MMTV promoter P1196. B lympho-
ytes are the predominant effector cells for MMTV-en-
oded superantigens and in these cells, similar to
ammary epithelial cells, MMTV transcription can be
ncreased in response to the steroid hormone dexameth-
sone (King and Corley, 1990; Randall et al., 1993).
In this study we utilized our recently established firefly-
uciferase-based superantigen reporter assay to test
hether the total MMTV superantigen expression from a
ull-length provirus is altered in response to dexameth-
sone. Superantigen-expressing, dexamethasone-re-
ponsive hematopoietic progenitor cells with stably in-
roduced reporter provirus were used as the model sys-
em.
RESULTS
uperantigen-reporter expression from stably
ntegrated MMTV superantigen-reporter provirus
n hematopoietic progenitor cell lines
MMTV transcripts are present in the normal B cell
ineage from the B cell progenitor (pro B) to the B cell
tage (Lund and Corley, 1991). We have previously es-
ablished and used a superantigen–luciferase reporter
rovirus to analyze the regulation of the MMTV sag gene
n B cell progenitor and B cell lines after transient trans-
ection (Reuss and Coffin, 1998). The natural lifecycle of
etroviruses involves integration of the provirus into the
ost cell genome and thus the transcription of the pro-
irus is influenced by the status of cellular chromatin
rganization at the site of integration. In order to inves-
igate the regulation of sag gene expression of such an
ntegrated MMTV provirus in response to external stimuli
uch as steroid hormones we introduced the superanti-
en–luciferase reporter provirus Msag17-luc together
ith the puromycin resistence-conferring plasmid
J6Vpuro (Morgenstern and Land, 1990) into the bone-
arrow-derived hematopoietic progenitor cell lines
a/F3 and FDC-P1. These murine IL-3-dependent, non-
ransformed cell lines represent pro B and promyelocytic
ell types, respectively. Selection for cell growth in the
resence of puromycin resulted in 12 oligoclonal pools of
uromycin-resistant cells for each cell line (pools B1 to
12 for Ba/F3 and D1 to D12 for FDC-P1). These cell
ools were tested for their luciferase expression under rormal growth conditions. We found that all of the puro-
ycin-resistant cell pools had a luciferase activity that
as 4 to 5 orders of magnitude and 1 to 3 orders of
agnitude higher than in the untransfected Ba/F3 and
DC-P1 cells, respectively (Figs. 1B and 1D). In previous
ransient transfections with the same plasmids, the lu-
iferase signal was only 1 to 2 orders of magnitude
bove background in Ba/F3 cells (Reuss and Coffin,
998).
As a control for MMTV LTR-driven gene expression we
sed the plasmid pMAMneo-LUC (Clontech) containing
he firefly luciferase gene under the transcriptional reg-
lation of the MMTV LTR and additionally a neomycin-
esistance marker. Luciferase reporter gene expression
rom this plasmid is known to be dexamethasone-induc-
ble. Ba/F3 and FDC-P1 cells transfected with the plas-
id pMAMneo-LUC were selected for growth in the
resence of the antibiotic G418. For each cell line 12
418-resistant oligoclonal pools (A1 to A12 for Ba/F3, C1
o C12 for FDC-P1) were tested for their luciferase activity
nder normal growth conditions. We found that all cell
ools had a luciferase activity that was 1 to 3 orders of
agnitude and 3 to 4 orders of magnitude higher than in
he untransfected Ba/F3 and FDC-P1 control cells, re-
pectively (Figs. 1A and 1C).
These results show that in both Ba/F3 and FDC-P1
ells carrying stably integrated reporter plasmids, lucif-
rase expression directed by the MMTV LTR and lucif-
rase expression from the recombinant sag–luciferase
ene of a MMTV provirus can be detected under normal
rowth conditions in the absence of exogenously added
teroid hormone. Differences in expression levels be-
ween the individual, parallel cell pools are likely to result
rom G418-resistant cells that have not received the lu-
iferase reporter plasmid (in the case of the pMsag17-
uc/pJ6Vpuro cotransfection experiment), different num-
ers of reporter plasmids integrated into the genome,
nd position effects from integration into different loci
ithin the genome. For further experiments we randomly
elected three independent luciferase-expressing cell
ools for each of the cell lines and reporter constructs.
MTV sag gene expression is reduced in the
resence of dexamethasone
Our previous experiments demonstrated that promot-
rs within the 59 LTR of MMTV play no significant role in
he expression of the viral superantigen in the bone-
arrow-derived pro B cell line Ba/F3 and B lymphoma
ines (Reuss and Coffin, 1995, 1998) in the absence of
xogenously added glucocorticoid hormones. These ste-
oids are known to stimulate the rate of transcription
rom the classical MMTV 59 LTR promoter [P1196] in many
cell types including mammary epithelial cells and B lym-
phocytes. In contrast, the env gene promoter [P7246] is not
esponsive to dexamethasone (Elliott et al., 1988). To
d line.
es. The
100 TOVAR SEPU´LVEDA ET AL.determine whether MMTV sag gene expression is fur-
ther enhanced in the presence of steroid hormones we
used Ba/F3 and FDC-P1 cells stably transfected with
either the control plasmid pMAMneo-LUC or the MMTV
superantigen reporter provirus Msag17-luc. Three inde-
pendent oligoclonal pools each of Ba/F3 and FDC-P1
cells stably transfected with pMAMneo-LUC or pM-
FIG. 1. MMTV-controlled luciferase expression in mouse hematop
hematopoietic progenitor cell lines Ba/F3 and FDC-P1 stably transfecte
and C, pools C1 to C12 for FDC-P1) or the MMTV superantigen reporte
for FDC-P1) and the respective untransfected control cells grown in
expression. Luciferase activity is expressed as relative light units [RLU
and the plasmid pMAMneo-luc are depicted in E. The major transcri
sequences shown by a solid line and the introns are given by a dashe
an open box, and all other genes (gag, pro, pol, env, sag) as gray boxsag17-luc were randomly selected and grown in the
presence or absence of the synthetic glucocorticoiddexamethasone and the levels of luciferase expression
were determined. We found that expression of the lucif-
erase reporter gene under control of the MMTV LTR was
increased 5- to 8-fold in Ba/F3 cells and 7- to 16-fold in
FDC-P1 cells in response to dexamethasone (Fig. 2). In
contrast, expression of the sag–luciferase reporter gene
in the complete MMTV provirus was reduced to approx-
progenitor cell lines. Twelve oligoclonal pools each of the mouse
either the control plasmid pMAMneo-luc (A, pools A1 to A12 for Ba/F3,
us pMsag17-luc (B, pools B1 to B12 for Ba/F3, and D, pools D1 to D12
sence of dexamethasone were tested for firefly luciferase reporter
icrogram protein. The structures of the reporter provirus pMsag17-luc
nomic, env, sag) are represented below the plasmids with the exon
Promoters (P) are shown as black boxes, the luciferase gene (luc) as
U3, R, and U5 regions of the viral LTR are indicated.oietic
d with
r provir
the ab
] per m
pts (geimately 50 to 60% in Ba/F3 and 20 to 85% in FDC-P1 of
the uninduced control values under the same conditions.
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101MMTV Sag GENE EXPRESSIONWe conclude from these experiments that both hema-
topoietic cell lines Ba/F3 and FDC-P1 support the stim-
ulation of MMTV gene expression from the viral LTR by
dexamethasone. We observed increased expression of a
luciferase gene under the transcription control of a
MMTV LTR but reduced expression from the hybrid sag/
luc-gene of our superantigen-reporter MMTV provirus
following dexamethasone treatment. These data demon-
strate that MMTV superantigen expression does not cor-
relate with the transcriptional activity of the classical
steroid-inducible MMTV promoter P1196 in the U3 region
of the viral LTR and suggests that this promoter is not
significantly involved in the expression of the MMTV sag
gene in B lymphoid cells exposed to steroid hormones.
MMTV transcription in hematopoietic progenitor cells
is induced in response to dexamethasone
Three major size classes of MMTV transcripts are
commonly present in MMTV-infected cells: an approxi-
mately 8-kb genomic, full-length mRNA and the two sin-
gly spliced env- and putative sag-mRNAs of 3.8 and 1.7
kb, respectively (Robertson and Varmus, 1981; van Ooyen
et al., 1983; Wheeler et al., 1983). The structure of a 1.7-kb
sag mRNA has been determined and shown to consist of
a leader sequence derived from the 59 LTR and the
adjacent noncoding region spliced to a site 72 nucleo-
tides upstream of the 39 LTR and contain the entire sag
ene (van Ooyen et al., 1983; Wheeler et al., 1983). A
second type of sag mRNA with a similar size of 1.8 kb is
ranscribed from a promoter within the env gene (Zhang
t al., 1996). In order to characterize the size and relative
mounts of mRNA species expressed from our reporter
FIG. 2. Effect of dexamethasone on MMTV-controlled luciferase ex
oligoclonal pools each of hematopoietic progenitor cell lines Ba/F3 and
the MMTV superantigen reporter provirus pMsag17-luc and the respec
or absence (black bars) of dexamethasone (1 mM). The designation of
were lysed and the firefly luciferase activity was determined. Results
represent the arithmetic mean 6 SD of three parallel cultures per celrovirus Msag17-luc under steroid-free and glucocorti-
oid-induced conditions in hematopoietic progenitor
1
pells, we isolated total cellular RNA from dexamethasone
reated and untreated parallel cultures of Ba/F3 and
DC-P1 cell pools stably transfected with either the con-
rol construct pMAMneo-LUC or the superantigen-re-
orter construct pMsag17-luc. The cellular RNA was an-
lyzed by Northern blot after hybridization to a luciferase
ene probe.
In both Ba/F3 and FDC-P1 cells transfected with the
MAMneo-LUC control plasmid, we found a single major
NA species of approximately 3.4 kb in the absence of
examethasone (Fig. 3) consistent with the structure of
his construct. In dexamethasone-stimulated parallel cul-
ures of the same cells, the amount of RNA of this size
as drastically increased. The relative amount of 3.4 kb
NA in the cell pools analyzed correlated well with the
elative luciferase expression determined in Fig. 2: The
mount of luciferase RNA was generally higher in Ba/F3
ells than in FDC-P1 cells and was only weakly detect-
ble in pMAMneo-LUC-transfected FDC-P1 cell pools C2
nd C6. In Ba/F3 and FDC-P1 cells transfected with the
uperantigen-reporter construct pMsag17-luc in the ab-
ence of dexamethasone one major RNA species of
pproximately 3.4 kb and two minor RNAs at 9.7 and 5.4
b were present (Fig. 3). These RNAs correspond to the
.7-kb sag mRNA, the 8-kb genomic mRNA, and the
.8-kb env mRNA plus an additional 1.7-kb luciferase
nsert for each of these RNAs (Fig. 1). Following dexa-
ethasone treatment of these cells the amount of all
hree luciferase-encoding RNA species was found to be
trongly increased.
To determine whether the previously described sag
RNAs from the LTR and env promoters (Elliott et al.,
n in mouse hematopoietic progenitor cell lines. Three representative
1 stably transfected with either the control plasmid pMAMneo-Luc or
ransfected control cells were grown either in the presence (gray bars)
ls is identical to that in Fig. 1. Three parallel cultures of each cell pool
xpressed as relative light units [RLU] 1023 microgram protein21 andpressio
FDC-P
tive unt
cell poo988; van Ooyen et al., 1983) were present in the
Msag17-luc-transfected Ba/F3 and FDC-P1 cell pools
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102 TOVAR SEPU´LVEDA ET AL.used, we generated oligo dT-primed cDNAs from the
cellular RNAs isolated above and amplified the relevant
MMTV cDNAs in two separate PCRs (Fig. 4). A PCR with
primers PC2 from the env gene and VT2 from the lucif-
erase gene was designed to detect the sag mRNA tran-
scribed from the env gene promoter P7246 (Fig. 4B). PCR
with primer PC1 from the U5 region and primer VT2 is
expected to amplify the sag mRNA initiated at promoters
within the 59 LTR (Fig. 4C).
In all Ba/F3 cell pools transfected with the superanti-
gen reporter provirus pMsag17-luc we find, after PCR
with primers PC2/VT2, a 550-bp fragment that is charac-
FIG. 3. Northern blot analysis of dexamethasone-induced stimulation
f MMTV-controlled transcription in mouse hematopoietic progenitor
ell lines. Three representative oligoclonal pools each of hematopoietic
rogenitor cell lines Ba/F3 and FDC-P1 stably transfected with either
he control plasmid pMAMneo-Luc or the MMTV superantigen reporter
rovirus pMsag17-luc and the respective untransfected control cells
ere grown either in the presence (1) or in the absence (2) of
examethasone. Total cellular RNA was isolated and 13 mg RNA per
ane was separated on a denaturing agarose gel, transferred onto a
ylon membrane, and successively hybridized to a luciferase- and
b-actin probe. The 0.24- to 9.5-kb RNA ladder (GibcoBRL) was used as
a size marker. The position and size of the luciferase mRNA from
control plasmid pMAMneo-luc (luc), and luciferase gene-containing
transcripts from MMTV reporter provirus Msag17-luc (genomic 1 luc,
nv 1 luc, sag 1 luc) are indicated.teristic for the sag mRNA initiated at the env gene pro-
moter P7246 (Fig. 4B). Sequence analysis of two clonedfragments confirm the RNA structure described by Elliot
et al. (Elliott et al., 1988). Minor amounts of larger PCR
roducts are likely to represent the env mRNA and minor
plice variants. No differences were found between sam-
les from cells grown in the presence or absence of
examethasone. No PCR products were detected in un-
ransfected Ba/F3 cells. The same results were obtained
or the corresponding FDC-P1 cell pools (data not
hown). PCR amplification of putative sag mRNA from
romoters within the 59 LTR generated major fragments
f 1500, 950, and 740 bp (Fig. 4C). The 740-bp product,
ith the predicted size for the sag mRNA, was isolated
nd cloned. Sequence analysis of two independent
lones confirmed the sag mRNA structure reported ear-
lier (van Ooyen et al., 1983). Preliminary data suggest
that the two larger sized products of 1500 and 950 bp are
env mRNA splice variants. Increased amounts of the sag
mRNA, as indicated by the 740-bp product, are present in
FIG. 4. RT-PCR analysis of sag mRNAs transcribed from the super-
antigen reporter provirus Msag17-luc. (A) Schematic representation of
MMTV provirus with the position of promoters (P), sag gene, luciferase
gene (luc), and mRNAs (genomic, env, sag RNAs). The position and
polarity of PCR primers (PC1, PC2, VT2) is indicated by an arrowhead.
The calculated size of PCR products for the primer combinations
PC1/VT2 and PC2/VT2 is shown for each mRNA. Total cellular RNA
from Ba/F3 cells or Ba/F3 cell pools B2, B6, and B9 transfected with
MMTV superantigen-reporter plasmid pMsag17-luc that were grown in
the presence (1Dex) or absence (2Dex) of dexamethasone was re-
verse transcribed with oligo-dT as primer. The cDNAs were used in
PCRs with primers PC2 and VT2 (B) to amplify sag mRNA initiated at a
promoter within the env gene or (C) with primers PC1 and VT2 to detect
sag mRNAs transcribed from a promoter within the 59 LTR. Bacterio-
phage l DNA digested with EcoRI and HindIII was used as a size
marker (M) and 2.5 ng of plasmid pMAMneo-luc was used as a
template in a positive control reaction (K). The position (filled square)
and size of the major PCR products are indicated.
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103MMTV Sag GENE EXPRESSIONRNA from cells grown in the presence of dexamethasone
when compared to RNA from untreated cells. No PCR
products were detected in untransfected Ba/F3 cells.
The same results were obtained for the corresponding
FDC-P1 cell pools (data not shown).
These data show that both hematopoietic progenitor
cell lines Ba/F3 and FDC-P1 support the dexametha-
sone-dependent stimulation of transcription from the
MMTV 59 LTR present in control plasmid pMAMneo-LUC
and superantigen-reporter plasmid pMsag17-luc. In
agreement with earlier reports (Fine et al., 1974; Ringold
et al., 1977; Robertson and Varmus, 1981), dexametha-
sone treatment of superantigen-reporter pMsag17-luc-
expressing cells results in an increased production of
RNAs with a characteristic size for genomic, env-, and
sag-mRNAs. RT-PCR analysis shows that only a minor
part of spliced mRNAs from the 59 LTR promoter repre-
sent sag mRNA.
DISCUSSION
The mouse mammary tumor virus sag gene within the
LTR encodes isolate-specific superantigens that activate
specific T cell populations when expressed on the sur-
face of antigen-presenting cells (Acha Orbea and Mac-
Donald, 1995). Even before the function of sag was
known, the transcriptional mechanism for its expression
had been proposed: a 1.7-kb mRNA, present in infected
cells, initiated at the classical U3 promoter and spliced to
an acceptor site just upstream of the sag gene was the
nly candidate mRNA (van Ooyen et al., 1983; Wheeler et
al., 1983). Several years later Elliott et al. described for a
cell line a similarly sized, phorbol-ester-inducible, al-
ernative sag mRNA that was initiated at a promoter
ithin the env gene and spliced to the same acceptor
ite upstream of the sag gene (Elliott et al., 1988). The
ecent detection of “alternative” sag-mRNAs initiated at
he env gene promoter in B lymphoma cells (Xu et al.,
997; Zhang et al., 1996) raises the question about the
elative contribution of promoters within the LTR and the
nv gene to sag gene expression. The MMTV promoters
698 [P2] (Gu¨nzburg et al., 1993) and P8498 [Penv2] (Arroyo et
l., 1997) may also contribute to superantigen expres-
ion.
Most reports about the regulation of superantigen ex-
ression from the viral sag gene rely on the quantitative
nalysis of putative sag mRNAs, due to problems with
he detection and quantification of the superantigen pro-
ein. All conclusions about the level of superantigen
rotein based on these data remain circumstantial. We
ave previously developed and used a sensitive reporter
ssay for the superantigen expression from an infectious
MTV provirus. This assay is based on a recombinant
uperantigen–luciferase gene and yields information
bout the total amount of MMTV superantigen expres-
ion from all sag mRNAs combined (Reuss and Coffin,995, 1998). In the present study we have tested the
ffect of glucocorticoid hormone on total MMTV supe-
antigen expression.
According to the prevailing model for sag gene expres-
ion, in the absence of glucocorticoids superantigen is
xpressed from the glucocorticoid-unresponsive pro-
oter P7246 [Penv] within the env gene. Under these con-
itions, the activity of the major U3 promoter is generally
ow (Fine et al., 1974; Ringold et al., 1977; Robertson and
Varmus, 1981). Addition of the synthetic glucocorticoid
dexamethasone is expected to increase sag mRNA tran-
scription from the 59 LTR but leave sag expression from
he env gene promoter unchanged and thus result in a
et stimulation of total sag expression. However, we
ound that, contrary to the model, exposure of hemato-
oietic progenitor cell lines that are stably transfected
ith our proviral sag reporter plasmid pMsag17-luc to
examethasone led to a moderately (approximately 50%)
educed sag reporter expression. Control reporter ex-
pression from a MMTV LTR-driven luciferase gene in the
same cell lines was increased 5- to 16-fold under iden-
tical conditions. It is likely that the reduction of sag
expression in the presence of dexamethasone was due
to reduced accessibility of the env gene promoter for
transcription initiation when readthrough transcription
from the 59 LTR occurs, a phenomenon known as pro-
moter occlusion (Adhya and Gottesman, 1982). Alterna-
tively, reduced sag expression may result from a general
inhibitory effect of dexamethasone on cellular transcrip-
tion. Analysis of luciferase-coding RNAs in cells contain-
ing the sag–luciferase MMTV provirus in the absence of
dexamethasone revealed a single, major 3.4-kb RNA that
corresponds to a 1.7-kb sag RNA plus a 1.7-kb luciferase
gene (sag 1 luc). In dexamethasone-treated cells in-
creased amounts of the 3.4-kb RNA and large amounts of
a 9.7-kb genomic (genomic 1 luc) and a 5.4-kb env
(env 1 luc) RNA were detected. Surprisingly, the in-
creased amount of the 3.4-kb RNA did not result in an
increased sag–luciferase expression. RT-PCR analysis
shows that only a minor part of spliced mRNAs from the
59 LTR promoter represents sag mRNA.
We conclude from these experiments that in hemato-
poietic progenitor cell lines a 1.7-kb sag RNA is tran-
scribed from an MMTV provirus and used for the expres-
sion of the sag gene in the absence of dexamethasone.
Our previous data demonstrate that superantigen ex-
pression under these conditions is independent of pro-
moters in the viral LTR and suggest that this RNA is
generated from a promoter within the env gene (Reuss
and Coffin, 1995, 1998). Dexamethasone treatment stim-
ulates the production of equally sized (1.7 kb) mRNA from
the hormone-inducible LTR promoter along with the env-
and genome-size transcripts. However, this 1.7-kb tran-
script does not increase the expression of MMTV su-
perantigens. It may be speculated that this LTR-derived
sag mRNA is either present in small amounts relative to
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104 TOVAR SEPU´LVEDA ET AL.the env promoter-derived sag mRNA or may be subject to
osttranscriptional regulation. From the deduced se-
uence of the two different 59 exons, no change of mRNA
oding capacity is apparent.
These data suggest that for a full-length MMTV provi-
us transcripts from the 59 LTR are largely retained as
genomic RNAs or spliced into env mRNAs and env
mRNA splice variants. The major amount of superantigen
is generated from transcripts initiated at a promoter
within the env gene. In apparent conflict with this model
is the situation for the defective endogenous MMTV
provirus Mtv-6. This provirus has lost most of the internal
oding region including the env gene promoter but is still
ble to express sufficient amounts of superantigen to
irect thymic deletion of a specific T cell subset (Cho et
l., 1995). However in Mtv-6 the loss of the env gene
romoter is compensated by the deletion of the env gene
plice acceptor. In Mtv-6 only one splice donor site
ownstream from the 59 LTR and one splice acceptor site
pstream of the sag gene remain and efficient use of
hese sites generates predominantly sag gene mRNA
Cho et al., 1995). No competition for splicing occurs
etween env and sag mRNAs. Superantigen expression
rom the Mtv-6 provirus is thus postulated to be dexam-
ethasone-responsive.
For intact, infectious MMTV our data demonstrate re-
duced sag gene expression in the presence of dexa-
methasone and establish that not all MMTV genes are
dex-inducible. Potential underlying mechanisms, cur-
rently under investigation, include reduced transcription,
splicing or translation, promoter occlusion, direct or in-
direct action of dexamethasone on the internal promoter,
and differences in translation efficiency between differ-
ent sag mRNAs.
MATERIALS AND METHODS
Plasmids and recombinant viral constructs
The Mtv-1/C3H-recombinant proviral clone “hybrid
MMTV” in pBR322 (Shackleford and Varmus, 1988) was a
gift from H. Varmus. References to nucleotide positions
are based on Mtv-1 LTR (Crouse and Pauley, 1989) and
C3H LTR (Majors and Varmus, 1983) for 59 and 39 LTR
and MMTV (BR6) (Moore et al., 1987) for the internal
region. The designation for MMTV promoters used
throughout the manuscript identifies the promoters (P698,
P1196, P7246, P8498) by the position of the major transcription
initiation site within the reference proviral sequence
MMTV (BR6) (Moore et al., 1987). The superantigen–
luciferase reporter plasmid pMsag17-luc described ear-
lier (Reuss and Coffin, 1998) is based on the hybrid
MMTV provirus (Shackleford and Varmus, 1988). The
plasmid pMAMneo-LUC (Clontech) contains a MMTV
LTR directing the expression of a firefly luciferase gene
and also includes a neomycin-resistance marker. Plas-
mid pJ6Vpuro, a gift from J. Morgenstern, is derived from
s
gplasmid pJ4Vpuro (Morgenstern and Land, 1990) by re-
placing the MLV LTR with the rat b-actin promoter.
Cell lines and transfection procedures
The interleukin-3-dependent mouse progenitor cell
lines Ba/F3 (Palacios and Steinmetz, 1985) and FDC-P1
(Dexter et al., 1980), a gift from U. Klingmu¨ller, were
maintained in RPMI 1640 medium supplemented with
10% fetal calf serum, 10% WEHI 3B-conditioned medium,
penicillin (100 Ul/ml), and streptomycin (100 mg/ml).
m5MT, a mouse mammary-gland-derived epithelial cell
ine used as a source of MMTV virions, was cultured in
ulbecco’s modified Eagle’s medium supplemented with
0% fetal calf serum, penicillin (100 Ul/ml), and strepto-
ycin (100 mg/ml). For the selection of antibiotic resistant
cells Puromycin (Sigma) or G418 sulfate (Gibco/BRL)
were used at a concentration of 1.5 mg/ml and 0.5 mg/ml,
espectively. MMTV transcription and production were
timulated by adding dexamethasone (Sigma) to a 1 mM
final concentration. DNA was introduced by electropora-
tion with a Biorad Genepulser. Equimolar amounts of test
plasmids (2 pmol) were linearized outside of the cloned
provirus with a restriction enzyme. Carrier plasmid
pGEM-2 and TE (10 mM Tris, 1 mM EDTA, pH 7.0) were
added to a constant DNA amount and volume.
Reporter gene assay
Cells were harvested, washed twice in PBS (137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4),
nd lysed in reporter lysis buffer (Promega). The lucif-
rase assay system (Promega) was used for detection of
irefly luciferase (duplicate assays). Light emission was
etermined for 10 s in a ILA911 luminometer (Tropix) or
umat LB 9501 (Berthold, Germany). Protein concentra-
ion of cellular extracts was measured with the Bio-Rad
rotein assay.
NA extraction and Northern blot analysis
Total cellular RNA was isolated with the RNeasy kit
Qiagen). RNA concentration was determined in a Ultro-
pec II photometer (LKB). The RNA was separated in a
orizontal, denaturing formaldehyde–agarose gel elec-
rophoresis (Ausubel, 1997), transferred to a Hybond-N
Amersham) nylon membrane, and covalently bound to
he membrane by exposure to UV light in a UV Strata-
inker 1800 (Stratagen). DNA probes used were the XbaI/
laI fragment of the luciferase gene from nt 1695 to 3012
f plasmid pMAMneo-LUC (Clontech) and the human
b-actin cDNA as XhoI fragment from plasmid pHFbA-1
(Gunning et al., 1983). DNA restriction fragments were
gel purified, radioactively labeled by random primed
DNA synthesis in the presence of [a-32P]dCTP with the
NA-polymerase Klenow fragment (Ausubel, 1997), and
eparated from unincorporated nucleotides by centrifu-
ation though a P30 (Bio-Rad) column. Hybridization was
f
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after exposure to X-OMAT AR (Kodak) film.
RT-PCR analysis and DNA sequence determination
The RNA (2.5 mg each) was incubated with Superscript
MLV reverse transcriptase (Life Science/BRL) in the
presence of oligo dT12–18 primer according to the manu-
acturer’s protocol followed by heat inactivation at 70°C
or 15 min. The cDNA was amplified using recombinant
aq DNA polymerase (Life Technologies) with primers
C1 (59 GTG TTT GTG TCT GTT CGC CA 39) correspond-
ng to positions 1197 to 1216 in the U5 region of the Mtv-1
TR (Crouse and Pauley, 1989) and VT2 (59 ACT ACG GTA
GC TGC GAA ATG 39) complementary to codons 119 to
26 of the firefly luciferase gene or primers PC2 (59 GAG
CG AGT CTG CTC CTC CA 39) corresponding to posi-
ions 7411 to 7430 in the MMTV env gene (Moore et al.,
987) and VT2. The PCR products were separated on a
.2% agarose gel and stained with ethidium bromide. For
NA sequence determination the PCR products were
urified with the Qiaquick PCR purification kit (Qiagen),
reated with the Klenow fragment of DNA polymerase I
nd T4-polynucleotide kinase to generate blunt-ended,
hosphorylated fragments, and cloned into the SmaI site
f vector pUC18. Sequence analysis was done with pUC
equencing primer (59 GAA AAA CGA CGG CCA GT 39),
UC reverse sequencing primer (59 CAG GAA ACA GCT
TG AC 39), and primer luc 5.3 (59 CTC TAG AGG ATA
AA TGG 39) in combination with the T7 sequencing kit
Pharmacia Biotech).
ACKNOWLEDGMENTS
We are grateful to H. zur Hausen for support, to U. Klingmu¨ller, J.
Morgenstern, E.-M. de Villiers, and H. Varmus for their generous gifts of
cell lines or reagents, and to U. Ackermann for expert photographic
assistance. J.M.C. is an American Cancer Society Professor of Molec-
ular Biology and Microbiology. This work was supported by National
Cancer Institute Award R35 CA44385 to J.M.C. and a Leukemia Society
of America Fellowship to F.U.R.
REFERENCES
Acha Orbea, H., and MacDonald, H. R. (1995). Superantigens of mouse
mammary tumor virus. Annu. Rev. Immunol. 13, 459–486.
dhya, S., and Gottesman, M. (1982). Promoter occlusion: Transcription
through a promoter may inhibit its activity. Cell 29, 939–944.
rroyo, J., Winchester, E., McLellan, B., and Huber, B. T. (1997). Shared
promoter elements between a viral superantigen and the major
histocompatibility complex class II-associated invariant chain. J. Vi-
rol. 71, 1237–1245.
usubel, F. M. e. a., Ed. (1997). Current Protocols in Molecular Biology.
(V. B. Chanda, Ed.), 3 vols, Wiley, New York.
eutner, U., Kraus, E., Kitamura, D., Rajewsky, K., and Huber, B. T. (1994).
B cells are essential for murine mammary tumor virus transmission,
but not for presentation of endogenous superantigens. J. Exp. Med.
179(5), 1457–1466.
ittner, J. J. (1936). Some possible effects of nursing on the mammary
gland tumor incidence in mice. Science 84, 162–169.
Cho, K., Ferrick, D. A., and Morris, D. W. (1995). Structure and biologicalactivity of the subgenomic Mtv-6 endogenous provirus. Virology
206(1), 395–402.
Crouse, C. A., and Pauley, R. J. (1989). Molecular cloning and sequenc-
ing of the MTV-1 LTR: Evidence for a LTR sequence alteration. Virus
Res. 12(2), 123–137.
Dexter, T. M., Garland, J., Scott, D., Scolnick, E., and Metcalf, D. (1980).
Growth of factor-independent hemopoietic precursor cell lines. J.
Exp. Med. 152, 1036–1047.
Elliott, J. F., Pohajdak, B., Talbot, D. J., Shaw, J., and Paetkau, V. (1988).
Phorbol diester-inducible, cyclosporine-suppressible transcription
from a novel promoter within the mouse mammary tumor virus env
gene. J. Virol. 62(4), 1373–1380.
Fine, D. L., Plowman, J. K., Kelley, S. P., Arthur, L. O., and Hillman, E. A.
(1974). Enhanced production of mouse mammary tumor virus in
dexamethasone-treated, 5-iododeoxyridine-stimulated mammary tu-
mor cell cultures. J. Natl. Cancer Inst. 52(6), 1881–1886.
Frankel, W. N., Rudy, C., Coffin, J. M., and Huber, B. T. (1991). Linkage of
Mls genes to endogenous mammary tumor viruses of inbred mice.
Nature 349, 526–528.
Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., and Kedes, L.
(1983). Isolation and characterization of full-length cDNA clones for
human a, b and g-actin mRNAs: Skeletal but not cytoplasmic actins
have an amino-terminal cystein that is subsequently removed. Mol.
Cell. Biol. 3, 787–795.
Gu¨nzburg, W. H., Heinemann, F., Wintersperger, S., Miethke, T., Wagner,
H., Erfle, V., and Salmons, B. (1993). Endogenous superantigen ex-
pression controlled by a novel promoter in the MMTV long terminal
repeat. Nature 364(6433), 154–158.
Hainaut, P., Vaira, D., Francois, C., Calberg, B. C. M., and Osterrieth,
P. M. (1985). Natural infection of Swiss mice with mouse mammary
tumor virus (MMTV): Viral expression in milk and transmission of
infection. Arch. Virol. 83(3–4), 195–206.
Held, W., Shakhov, A. N., Izui, S., Waanders, G. A., Scarpellino, L.,
MacDonald, H. R., and Acha Orbea, H. (1993a). Superantigen-reac-
tive CD41 T cells are required to stimulate B cells after infection with
mouse mammary tumor virus. J. Exp. Med. 177(2), 359–366.
Held, W., Waanders, G. A., Shakhov, A. N., Scarpellino, L., Acha Orbea,
H., and MacDonald, H. R. (1993b). Superantigen-induced immune
stimulation amplifies mouse mammary tumor virus infection and
allows virus transmission. Cell 74(3), 529–540.
Kappler, J. W., Staerz, U., White, J., and Marrack, P. C. (1988). Self-
tolerance eliminates T cells specific for Mls-modified products of the
major histocompatibility complex. Nature 332, 35–40.
King, L. B., and Corley, R. B. (1990). Lipopolysaccharide and dexameth-
asone induce mouse mammary tumor proviral gene expression and
differentiation through distinct regulatory pathways. J. Immunol.
10(8), 4211–4220.
Liegler, T. J., and Blair, P. B. (1986). Direct detection of exogenous
mouse mammary tumor virus sequences in lymphoid cells of BALB/
cfC3H female mice. J. Virol. 59(1), 159–162.
Lund, F. E., and Corley, R. B. (1991). Regulated expression of mouse
mammary tumor proviral genes in cells of the B lineage. J. Exp. Med.
174(6), 1439–1450.
Majors, J. E., and Varmus, H. E. (1983). Nucleotide sequencing of an
apparent proviral copy of env mRNA defines determinants of expres-
sion of the mouse mammary tumor virus env gene. J. Virol. 47(3),
495–504.
Miller, C. L., Garner, R., and Paetkau, V. (1992). An activation-dependent,
T-lymphocyte-specific transcriptional activator in the mouse mam-
mary tumor virus env gene. Mol. Cell. Biol. 12(7), 3262–3272.
Moore, R., Dixon, M., Smith, R., Peters, G., and Dickson, C. (1987).
Complete nucleotide sequence of a milk-transmitted mouse mam-
mary tumor virus: Two frameshift suppression events are required for
translation of gag and pol. J. Virol. 61(2), 480–490.Morgenstern, J. P., and Land, H. (1990). Advanced mammalian gene
transfer: High titre retroviral vectors with multiple drug selection
PP
R
R
R
R
R
S
T
v
W
X
Z
106 TOVAR SEPU´LVEDA ET AL.markers and a complementary helper-free packaging cell line. Nu-
cleic Acids Res. 18(12), 3587–3596.
Nandi, S., and McGrath, C. M. (1973). Mammary neoplasia in mice. Adv.
Cancer Res. 17, 353–414.
alacios, R., and Steinmetz, M. (1985). II-3-dependent mouse clones
that express B-220 surface antigen, contain Ig genes in germ-line
configuration, and generate B lymphocytes in vivo. Cell 41(3), 727–
734.
ullen, A. M., Wade, T., Marrack, P., and Kappler, J. W. (1990). Identifi-
cation of the region of T cell receptor beta chain that interacts with
the self-superantigen Mls-1a. Cell 61(7), 1365–1374.
andall, T. D., Lund, F. E., Brewer, J. W., Aldridge, C., Wall, R., and Corley,
R. B. (1993). Interleukin-5 (IL-5) and IL-6 define two molecularly
distinct pathways of B-cell differentiation. Mol. Cell. Biol. 13(7), 3929–
3936.
euss, F. U., and Coffin, J. M. (1995). Stimulation of mouse mammary
tumor virus superantigen expression by an intragenic enhancer.
Proc. Natl. Acad. Sci. USA 92(20), 9293–9297.
euss, F. U., and Coffin, J. M. (1998). Mouse mammary tumor virus
superantigen expression in B cells is regulated by a central en-
hancer within the pol gene. J. Virol. 72(7), 6073–6082.
ingold, G. M., Yamamoto, K. R., Bishop, J. M., and Varmus, H. E. (1977).
Glucocorticoid-stimulated accumulation of mouse mammary tumor
virus RNA: Increased rate of synthesis of viral RNA. Proc. Natl. Acad.
Sci. USA 74(7), 2879–2883.
obertson, D. L., and Varmus, H. E. (1981). Dexamethasone induction ofthe intracellular RNAs of mouse mammary tumor virus. J. Virol. 40(3),
673–682.
hackleford, G. M., and Varmus, H. E. (1988). Construction of a clon-
able, infectious, and tumorigenic mouse mammary tumor virus pro-
virus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA
85(24), 9655–9659.
siagbe, V. K., Yoshimoto, T., Asakawa, J., Cho, S. Y., Meruelo, D., and
Thorbecke, G. J. (1993). Linkage of superantigen-like stimulation of
syngeneic T cells in a mouse model of follicular center B cell
lymphoma to transcription of endogenous mammary tumor virus.
EMBO J. 12(6), 2313–2320.
an Ooyen, A., Michalides, R. J., and Nusse, R. (1983). Structural anal-
ysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA.
J. Virol. 46(2), 362–370.
heeler, D. A., Butel, J. S., Medina, D., Cardiff, R. D., and Hager, G. I.
(1983). Transcription of mouse mammary tumor virus: Identification of
a candidate mRNA for the long terminal repeat gene product. J. Virol.
46(1), 42–49.
u, L., Wrona, T. J., and Dudley, J. P. (1997). Strain-specific expression of
spliced MMTV RNAs containing the superantigen gene. Virology
236(1), 54–65.
hang, D. J., Tsiagbe, V. K., Huang, C., and Thorbecke, G. J. (1996).
Control of endogenous mouse mammary tumor virus superantigen
expression in SJL lymphomas by a promoter within the env region.
J. Immunol. 157(8), 3510–3517.
